Xceleron grabs a piece of American pie
UK-based microdosing specialist Xceleron has announced its expansion with the takeover of a new facility in the US, two years after setting up a business base in the region.
UK-based microdosing specialist Xceleron has announced its expansion with the takeover of a new facility in the US, two years after setting up a business base in the region.
Sanofi-Aventis' disposable insulin pen SoloStar has been launched across the US for use with the company's 24-hour basal insulin Lantus (insulin glargine), despite patent infringement claims emanating from fellow insulin pen manufacturer, Novo Nordisk.
The concept of a "Super Combination Traveler's Vaccine" has come one step closer to reality with the initiation of a Phase II study on a single dose, oral typhoid fever vaccine.
Nikon have launched a new 'hands off' system that combines an incubator and inverted microscope to allow automated live-cell culture studies and time-lapse imaging in a controlled environment.
China continues to take steps toward drug safety reforms as it forges closer ties with US regulators and shuts down dodgy manufacturing plants.
US-based biopharma company BioWa has found a way of increasing an antibody's ability to initiate the complement immune system and blow holes in tumour cells.